UPSTREAM BIO, INC. (UPB) ROE
- 2026-06-30: ROE -57.76%.
- 2026-03-31: ROE -51.57%.
- 2025-12-31: ROE -42.22%.
- 2025-09-30: ROE -32.29%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -57.76% |
| 2026-03-31 | -51.57% |
| 2025-12-31 | -42.22% |
| 2025-09-30 | -32.29% |
| 2025-06-30 | -25.56% |
| 2025-03-31 | -17.77% |
| 2024-12-31 | -13.37% |
| 2024-09-30 | 33.31% |
| 2024-06-30 | 27.63% |
| 2024-03-31 | 21.27% |
| 2023-12-31 | 16.68% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -42.22% |
| 2024-12-31 | -13.37% |
| 2023-12-31 | 16.68% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |